BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26082202)

  • 1. Knockdown of PKM2 induces apoptosis and autophagy in human A549 alveolar adenocarcinoma cells.
    Chu B; Wang J; Wang Y; Yang G
    Mol Med Rep; 2015 Sep; 12(3):4358-4363. PubMed ID: 26082202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
    Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
    Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
    Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
    J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of PKM2 leads to impaired glycolysis and cell death in 2-demethoxy-2,3-ethylenediamino hypocrellin B-photoinduced A549 cells.
    Zhou Z; Liu Y; Qin M; Sheng W; Wang X; Li Z; Zhong R
    J Photochem Photobiol B; 2014 May; 134():1-8. PubMed ID: 24792468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
    Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways.
    Feng J; Ma T; Ge Z; Lin J; Ding W; Chen H; Zhu W; Zhou S; Tan Y
    Mol Med Rep; 2015 Mar; 11(3):2111-7. PubMed ID: 25411978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of autophagy-related gene BECLIN1 promotes cell growth and inhibits apoptosis in the A549 human lung cancer cell line.
    Wang W; Fan H; Zhou Y; Duan P; Zhao G; Wu G
    Mol Med Rep; 2013 May; 7(5):1501-5. PubMed ID: 23525201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.
    Sun H; Zhu A; Zhang L; Zhang J; Zhong Z; Wang F
    Int J Mol Sci; 2015 Oct; 16(10):24574-87. PubMed ID: 26501265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
    Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.
    Yuan S; Qiao T; Zhuang X; Chen W; Xing N; Zhang Q
    Yonsei Med J; 2016 Nov; 57(6):1312-23. PubMed ID: 27593857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
    Yuan Q; Yu H; Chen J; Song X; Sun L
    Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.
    Yan J; Zhang D; Han Y; Wang Z; Ma C
    J Cell Biochem; 2019 Oct; 120(10):17303-17311. PubMed ID: 31106485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion.
    Xu Y; Chu L; Yuan S; Yang Y; Yang Y; Xu B; Zhang K; Liu XY; Wang R; Fang L; Chen Z; Liang Z
    Cell Death Dis; 2017 Jun; 8(6):e2835. PubMed ID: 28569774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells.
    Guo CY; Yan C; Luo L; Goto S; Urata Y; Xu JJ; Wen XM; Kuang YK; Tou FF; Li TS
    Oncol Rep; 2017 Apr; 37(4):2161-2166. PubMed ID: 28259998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Silencing pyruvate kinase M2 sensitizes human prostate cancer PC3 cells to gambogic acid-induced apoptosis].
    Lü L; Wang L; Jiang GS; Zhang CH; Zeng FQ
    Zhonghua Nan Ke Xue; 2013 Feb; 19(2):102-6. PubMed ID: 23441447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells.
    Yan XL; Zhang XB; Ao R; Guan L
    J Cell Biochem; 2017 Dec; 118(12):4792-4803. PubMed ID: 28543190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
    Li C; Zhao Z; Zhou Z; Liu R
    Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose.
    Li X; Deng S; Liu M; Jin Y; Zhu S; Deng S; Chen J; He C; Qin Q; Wang C; Zhao G
    Cell Death Dis; 2018 Jan; 9(2):133. PubMed ID: 29374159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.